ERBB2 and breast cancer: Interestingly, the cell growth of ER and HER2 negative HCC1806 breast cancer cell line was also clearly attenuated by siNRIP1, suggesting the involvement of other signaling pathways in siNRIP1 suppressed cell growth in addition to the activation of ER.